Merck Korea and Incheon sign MOU on biopharm

Home > Business > Industry

print dictionary print

Merck Korea and Incheon sign MOU on biopharm

Pharmaceutical giant Merck Korea signed a memorandum of understanding (MOU) with the Incheon Free Economic Zone on Monday to cooperate on the development of the local biotechnology industry.

Songdo in Incheon is fast becoming a sort of mecca for the country’s pharmaceutical industry as leading companies like Samsung BioLogics and Celltrion have nested in the area and foreign companies are setting up research and training centers to take advantage of the area’s established industry networks. Just last month, Merck relocated its biotech research center from Pangyo in Gyeonggi to Songdo in Incheon and expanded the facility. The so-called M Lab Collaboration Center will provide local companies with resources including expertise from Merck’s own engineers to help raise local talent and boost the country’s biopharmaceutical industry.

Cooperation between Merck and the Incheon economic zone will encompass “research on biopharmaceutical processes, logistics service and investment on production facilities,” the company said Monday.

More in Industry

Chuseok delivery strike canceled as headcount increased

BMW Motorrad channels 1936 for its latest bike

Battery business IPO won't affect LG Chem's controlling stake, company says

Hyundai Construction Equipment signs Algeria forklift deal

FSS permits financial sector workers to use networks remotely

Log in to Twitter or Facebook account to connect
with the Korea JoongAng Daily
help-image Social comment?
lock icon

To write comments, please log in to one of the accounts.

Standards Board Policy (0/250자)

What’s Popular Now